Become a KQED Sponsor
upper waypoint
Forum

Have We Learned How to Talk About GLP1s?

Mina Kim
Save ArticleSave Article
Failed to save article

Please try again

Photo Illustration of the new Wegovy semaglutide tablets with injectable prescription weight loss medicines, Ozempic, Victoza and Wegovy. (Michael Siluk/UCG/Universal Images Group via Getty Images)

Airdate: Tuesday, April 28 at 10 AM

An estimated one in eight Americans has now tried a GLP-1 medication like Ozempic or WeGovy: to lose weight, manage diabetes or experiment with anecdotal, off-label benefits. Yet GLP-1s can be hard to talk about — whether you want to ask someone if they take one, respond if you do, or discuss weight without dredging up unhealthy diet discourse. We’ll hear how you’re navigating these conversations in the age of GLP-1s. Tell us: How are GLP-1s showing up in your world?

Guests:

Diana Thiara, medical director, UCSF Weight Loss Management Program

Whitney Casares, pediatrician; author, “Raising Body-Confident Kids” and “My One-Of A-Kind Body: The Ultimate Guide to Caring for Me”

Angela Corral, senior editor, KQED’s The California Report; she has been been taking a GLP-1 for almost 2 years

Become a KQED Sponsor

lower waypoint
next waypoint
Player sponsored by